Navigation Links
The 2013 HFSP Nakasone Award goes to Stephen Quake of Stanford University
Date:9/18/2012

The Human Frontier Science Program Organization (HFSPO) is pleased to announce that the 2013 HFSP Nakasone Award has been conferred upon Stephen Quake of Stanford University for his pioneering inventions and discoveries that made innovative physical techniques available for biology and that are revolutionizing biophysics, biological automation, genome analysis, and personalized medicine. His work is making it easy to answer and, in some cases, to ask questions that were previously impossible to address, and has profound impact for nearly every area of biology.

The HFSP Nakasone Award was established to honour scientists who have made key breakthroughs in fields at the forefront of the life sciences. It recognizes the vision of former Prime Minister Nakasone of Japan in the creation of the Human Frontier Science Program. Stephen Quake will present the HFSP Nakasone Lecture at the annual meeting of HFSP awardees to be held in Strasbourg, France, in July 2013.

Through his work Stephen Quake developed key technologies that enabled advances in a broad range of fields from single molecule biophysics to molecular biology and microbial ecology. New large-scale quantitative approaches are revolutionizing nearly every aspect of the biological sciences. Stephen Quake is directly responsible for a truly remarkable number of these innovations, which is reflected in the large number of widely cited papers and patents he has published.

Quake and his group developed a precision method for time-resolved force spectroscopy called FemtoNewton Force Spectroscopy which enables a deeper understanding of both colloidal hydrodynamics and DNA force fluctuations. He was also the first to demonstrate single molecule DNA sequencing, followed by its successful commercialization as not only the first single molecule sequencer, but also the first sequencer of any kind capable of sequencing the human genome with a single instrument.

His pioneering efforts extend to the field of microfluidics and its application to biophysics. Microfluidics, which is essentially miniaturized plumbing, offers the possibility of solving outstanding automation issues in biology and chemistry. Stephen Quake's basic research in this area has led to the development of new biophysical measurement technology and its application to a broad variety of questions. One of his seminal contributions in this field was the development of the first microfluidic large-scale integration, fabricating chips with thousands of mechanical valves, fundamentally redefining the field.

Steven Quake has used this new technology to explore a number of questions of fundamental biophysical interest, such as the development of physics-based approaches to protein crystallization and structural biology, the application of molecular affinity measurements to large-scale mapping of transcription-factor binding properties, and the development of single cell genomics.

Stephen Quake is Professor of Bioengineering and a Howard Hughes Medical Institute Investigator at the James H. Clark Center, Department of Bioengineering at Stanford University, California, USA. His work has been honored in the past by prestigious awards including the 2012 Lemelson-MIT prize.


'/>"/>

Contact: Guntram Bauer
communications@hfsp.org
Human Frontier Science Program
Source:Eurekalert

Related biology news :

1. Neurobiologist Rodal wins New Innovator award
2. Madidi conservationist wins award at World Conservation Congress
3. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
4. MARC travel awards announced for the 2012 APS Integrative Biology of Exercise meeting
5. MARC travel awards announced for the 2012 SACNAS Annual Meeting
6. Stanford bioengineer Christina Smolke wins NIH Directors Pioneer Award
7. A rare feat: 2 scientists at Salk score NIH New Innovator Awards
8. Daniel Kahnemans Thinking, Fast and Slow wins best book award from academies
9. NIH New Innovator Award helps Sanford-Burnham scientist pursue high-risk, high-reward project
10. NIBIB and HHMI announce graduate biomedical training awards
11. Jay Keasling wins Heinz Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Florida , February 16, 2017 ... with the infusion of innovative telemedicine application, new ... services that are experiencing a boom worldwide. The ... the advancement of technologies, services and new therapies ... (OTC: RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)... Pa. , Feb. 16, 2017  Windtree ... biotechnology company focusing on developing aerosolized KL4 surfactant ... from a preclinical influenza study showed that aerosolized ... survival in a well-established preclinical animal model. The ... a growing body of evidence that supports the ...
(Date:2/15/2017)... ... February 15, 2017 , ... Park Systems , ... a powerful AFM operating software that drastically boosts productivity with single click reliable nanoscale ... of the functions of setting up and taking the image once done manually by ...
(Date:2/15/2017)... Pa. , Feb. 15, 2017 Windtree ... company focused on developing aerosolized KL4 surfactant therapies for ... (including a slide presentation) at 8:00 AM EST on ... AEROSURF phase 2 clinical program, the recently announced closing ... and development activities. To participate in the ...
Breaking Biology Technology: